Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer

NCT01221987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2012-04-30

No results posted yet for this study

Summary

The current study will elucidate the human papillomavirus type distribution in a population of women diagnosed with cervical high grade pre-cancerous lesions and invasive cervical cancer in Sri Lanka.

Conditions

Interventions

PROCEDURE

Cervical sampling

Cervical biopsy or excision specimen testing for human papillomavirus deoxyribose nucleic acid types

OTHER

Data collection

Questionnaire completion

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-09-30
Completion
2010-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221987 on ClinicalTrials.gov